Skip to content

Application value of controlled intestinal preparation for emergency colonoscopy in patients with acute lower gastrointestinal hemorrhage

Application value of controlled intestinal preparation for emergency colonoscopy in patients with acute lower gastrointestinal hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020183
Enrollment
Unknown
Registered
2018-12-19
Start date
2018-12-17
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lower gastrointestinal bleeding

Interventions

controlled intestinal preparation group:The intestinal cleaning by Lactulose

Sponsors

Department of Gastroenterology, Army Special Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-75 years old male and female; (2) There is a history of blood-sucking disease (sickness = 5 days), and patients with upper gastrointestinal bleeding are excluded by gastroscopy; (3) Can understand the procedures and methods of this clinical study, and voluntarily participate in and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Suspected patients with acute abdomen; history of intestinal surgery, severe intestinal stenosis or obstruction, perforation; (2) Dysphagia; (3) Severe heart disease such as myocardial infarction, unstable angina, and chronic cardiac insufficiency (NYHA class III and IV); (4) Severe chronic renal failure; (5) With or without taking antihypertensive drugs, blood pressure control is poor (SBP = 160mmHg, or DBP = 100mmHg); (6) Electrolyte disorders, not suitable for intestinal preparation; (7) Mental and neurological disorders, who cannot correctly express their wishes; (8) Alcoholics and drug abusers and addicts; (9) Women of childbearing age are in pregnancy and lactation; (10) Patients who have participated in other clinical trials of drugs or medical devices in the past three months; (11) In combination with other diseases, the investigators believe that they cannot tolerate colonoscopy.

Design outcomes

Primary

MeasureTime frame
Boston score;Intestinal disease detection rate;Adverse reactions during bowel preparation;

Secondary

MeasureTime frame
Stool nature;Satisfaction;Endoscopic operating time;

Countries

China

Contacts

Public ContactChen Dongfeng

Department of Gastroenterology, Army Special Medical Center

Chendf1981@126.com+86 13883032812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026